{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:17:34Z","timestamp":1783023454086,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1011314"],"award-info":[{"award-number":["NRF-2021R1A2C1011314"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010274","name":"Daegu Gyeongbuk Institute of Science and Technology","doi-asserted-by":"publisher","award":["26-NT-01"],"award-info":[{"award-number":["26-NT-01"]}],"id":[{"id":"10.13039\/501100010274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.yexmp.2026.105025","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:39:12Z","timestamp":1768595952000},"page":"105025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation"],"prefix":"10.1016","volume":"145","author":[{"given":"Kyeong-Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105025_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1369\/0022155419852932","article-title":"Renal inflammation and fibrosis: a double-edged sword","volume":"67","author":"Black","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yexmp.2026.105025_bb0010","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","article-title":"Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation","volume":"45","author":"Chia","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexmp.2026.105025_bb0015","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.7150\/ijbs.72977","article-title":"AANG prevents Smad3-dependent diabetic nephropathy by restoring pancreatic \u03b2-cell development in db\/db mice","volume":"18","author":"Chung","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexmp.2026.105025_bb0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ndt\/gfae048","article-title":"Global health inequalities of chronic kidney disease: a meta-analysis","volume":"39","author":"Duff","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexmp.2026.105025_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161142","article-title":"Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases","volume":"133","author":"Fares","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2026.105025_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064540","article-title":"Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the global burden of disease study 2019","volume":"13","author":"Feng","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.yexmp.2026.105025_bb0035","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.2147\/DDDT.S521265","article-title":"Anthraquinones from Rheum officinale ameliorate renal fibrosis in acute kidney injury and chronic kidney disease","volume":"19","author":"Feng","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.yexmp.2026.105025_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response","volume":"85","author":"Flanders","year":"2004","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14712598.7.3.293","article-title":"Therapeutic potential of TGF-\u03b2 inhibition in chronic renal failure","volume":"7","author":"Gagliardini","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.yexmp.2026.105025_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/CS20201213","article-title":"Negative regulators of TGF-\u03b21 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities","volume":"135","author":"Gifford","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yexmp.2026.105025_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymthe.2023.12.009","article-title":"Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs","volume":"32","author":"Gu","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexmp.2026.105025_bb0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41401-024-01404-7","article-title":"Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology","volume":"46","author":"Guo","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexmp.2026.105025_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12882-025-04028-z","article-title":"The global, regional, and national patterns of change in the burden of chronic kidney disease from 1990 to 2021","volume":"26","author":"Guo","year":"2025","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and Meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105025_bb0075","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","article-title":"Tubulointerstitial injury and the progression of chronic kidney disease","volume":"27","author":"Hodgkins","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0080","doi-asserted-by":"crossref","first-page":"F1287","DOI":"10.1152\/ajprenal.00017.2008","article-title":"Aldosterone and TGF-\u03b21 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells","volume":"294","author":"Huang","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yexmp.2026.105025_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36253","article-title":"Alantolactone alleviates epithelial-mesenchymal transition by regulating the TGF-beta\/STAT3 signaling pathway in renal fibrosis","volume":"10","author":"Hwang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexmp.2026.105025_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5483\/BMBRep.2020.53.11.153","article-title":"Lin28a attenuates TGF-\u03b2-induced renal fibrosis","volume":"53","author":"Jung","year":"2020","journal-title":"BMB Rep."},{"issue":"Suppl","key":"10.1016\/j.yexmp.2026.105025_bb0100","first-page":"S11","article-title":"Plasminogen activator inhibitor-1 and diabetic nephropathy","volume":"10","author":"Lee","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.yexmp.2026.105025_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4093\/dmj.2022.0231","article-title":"Alantolactone attenuates renal fibrosis via inhibition of transforming growth factor \u03b2\/Smad3 Signaling pathway","volume":"48","author":"Lee","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.yexmp.2026.105025_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2026.105025_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/gm326","article-title":"Drug repositioning for personalized medicine","volume":"4","author":"Li","year":"2012","journal-title":"Genome Med."},{"key":"10.1016\/j.yexmp.2026.105025_bb0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0125","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13267","article-title":"TGF-\u03b2\/Smad signaling in chronic kidney disease: exploring post-translational regulatory perspectives (review)","volume":"30","author":"Li","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexmp.2026.105025_bb0130","series-title":"Prevalence and Disease Burden of Chronic Kidney Disease. Renal Fibrosis: Mechanisms and Therapies","first-page":"3","author":"Lv","year":"2019"},{"key":"10.1016\/j.yexmp.2026.105025_bb0135","series-title":"Renal Fibrosis: Mechanisms and Therapies","first-page":"347","article-title":"TGF-\u03b2\/Smad and renal fibrosis","author":"Ma","year":"2019"},{"key":"10.1016\/j.yexmp.2026.105025_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexmp.2026.105025_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","article-title":"Fibroblasts and myofibroblasts in renal fibrosis","volume":"92","author":"Meran","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/ijms18051039","article-title":"Chronic kidney disease and exposure to nephrotoxic metals","volume":"18","author":"Orr","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105025_bb0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.14336\/AD.2023.0222","article-title":"TGF-beta as a master regulator of aging-associated tissue fibrosis","volume":"14","author":"Ren","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.yexmp.2026.105025_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0165","series-title":"Sulfur Chemistry","first-page":"1","article-title":"Analysis of US FDA-approved drugs containing Sulfur atoms","author":"Scott","year":"2019"},{"key":"10.1016\/j.yexmp.2026.105025_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100160","article-title":"Renal regeneration: the role of extracellular matrix and current ECM-based tissue engineered strategies","volume":"10","author":"Sobreiro-Almeida","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.yexmp.2026.105025_bb0175","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.2147\/DDDT.S321879","article-title":"Puerarin alleviates UUO-induced inflammation and fibrosis by regulating the NF-\u03baB P65\/STAT3 and TGF\u03b21\/Smads signaling pathways","volume":"15","author":"Wang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.yexmp.2026.105025_bb0180","doi-asserted-by":"crossref","first-page":"G950","DOI":"10.1152\/ajpgi.00132.2011","article-title":"The extracellular matrix: an active or passive player in fibrosis?","volume":"301","author":"Wight","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.yexmp.2026.105025_bb0185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drudis.2015.09.017","article-title":"Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds","volume":"21","author":"W\u00fcrth","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexmp.2026.105025_bb0190","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1046\/j.1523-1755.2003.00162.x","article-title":"TGF-\u03b2 isoforms in renal fibrogenesis","volume":"64","author":"Yu","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2026.105025_bb0195","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1042\/CS20180243","article-title":"The preventive and therapeutic implication for renal fibrosis by targetting TGF-\u03b2\/Smad3 signaling","volume":"132","author":"Zhang","year":"2018","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105025_bb0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3892\/ijmm.2025.5603","article-title":"Role of the TGF-\u03b2\/Smad signaling pathway in the transition from acute kidney injury to chronic kidney disease (review)","volume":"56","author":"Zou","year":"2025","journal-title":"Int. J. Mol. Med."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:36:20Z","timestamp":1783020980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S0014480026000043"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105025","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105025"}}